Companies: 10,795·Total market cap: $144.5T
GelStat Corporation

GelStat Corporation

GSACOTCHealthcare● Active
$0.00
+$0.00(+50.00%)
Market Cap$185394
P/E Ratio
52W High$0.0005
52W Low$0.0002

GelStat Corporation (GSAC) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

gsac · pe ratio · data through Dec 31, 2024

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for GelStat Corporation (GSAC) measures how much investors pay for each dollar of the company's trailing earnings. GSAC's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31

Forward P/E
N/A
EPS (TTM)
-$0.00
TTM · diluted EPS
PEG Ratio
-0.02
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · GelStat Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2002 – 2024 · Annual
PE Ratio (TTM)
5Y Avg 2.8x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 3 fiscal years · Front-end computed
Average
2.8x
3-yr mean
Median
2.6x
3-yr midpoint
Minimum
1.3x
Lowest year
Maximum
4.4x
Highest year
1.3x
Min
Q1 · 25%2.6x
Median
Q3 · 75%4.4x
Max
Historically Low

At N/A, GSAC's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.

0th percentileHigher than 0 of 3 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
GelStat Corporation
GelStat CorporationYou
GSAC
$0MN/A-$0.00
Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc.
AOXG
$0M51.76x$0.00
Plant-Based Investment Corp.
Plant-Based Investment Corp.
CWWBF
$0MN/A-$0.23
4Front Ventures Corp.
4Front Ventures Corp.
FFNTF
$0MN/A-$0.14
Grapefruit USA, Inc.
Grapefruit USA, Inc.
GPFT
$1MN/A-$0.00
Link Reservations Inc.
Link Reservations Inc.
LRSV
$0MN/A-$0.00
Thoughtful Brands Inc.
Thoughtful Brands Inc.
PEMTF
$0MN/A-$0.00

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2024-12-31Latest
FY2024
$-0.00
2023-12-31
FY2023
$-0.00
2022-12-31
FY2022
$-0.00
2021-12-31
FY2021
$-0.00
2020-12-31
FY2020
$-0.00
2019-12-31
FY2019
4.44x$0.00
2018-12-31
FY2018
$-0.00
2014-12-31
FY2014
$-0.00
2013-12-31
FY2013
$-0.00
2012-12-31
FY2012
2.64x$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for GelStat Corporation (GSAC) measures how much investors pay for each dollar of the company's trailing earnings. GSAC's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.00 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

GSAC pe ratio · 6 questions

GSAC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via GSAC's SEC 10-K and 10-Q filings.

GSAC PE ratioWhat is GSAC PE ratioCurrent PE ratio of GSACGSAC PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · GelStat Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09